CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324577
- Phone
- 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 18,521 shares at $4.64 ($85,937)
- 4 Open-market buy Director bought 7,000 shares at $4.62 ($32,340)
- 4 Open-market buy Director bought 20,000 shares at $4.77 ($95,400)
- 4 Open-market buy Director bought 19,647 shares at $4.29 ($84,286)
- 4 Open-market buy Chief Scientific Officer bought 2,000 shares at $4.37 ($8,740)
- 8-K/A Event Material agreement · Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 17,200 shares at $4.53 ($77,916)
- 4 Open-market buy Director bought 10,000 shares at $4.49 ($44,900)
- 4 Open-market buy Director bought 9,438 shares at $4.74 ($44,736)
- 4 Open-market buy Director bought 400 shares at $5.00 ($2,000)
- 4 Open-market buy Director bought 3,664 shares at $5.20 ($19,053)
- 4 Open-market buy Director bought 10,000 shares at $5.48 ($54,800)
- 4 Open-market buy Director bought 10,000 shares at $5.06 ($50,600)
- 4 Open-market buy Director bought 12,189 shares at an average $5.08 ($61,978)
- 4 Open-market buy Director bought 7,543 shares at $4.86 ($36,659)
- 8-K/A Event Material agreement
Page 23 of 28 · 553 filings